comprehensive -WSS

comprehensive

author：fashion 2025-09-28 00:51:29 - browse：86178

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Why getting cancer drugs just got harder for rural patients

hotspot

WSS

How to address the problem of discarded donor organs

An inside look at PIPEs, biotech's buzzy new financing tool

Flu vaccine offering decent levels of protection this winter, new data show

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Why Talkspace is targeting Medicare, a tricky market

How to address the problem of discarded donor organs

leisure time

comprehensive

hotspot

Supreme Court strikes down use of affirmative action

IVF doctors demand details after CooperSurgical lawsuit

How one medical school became remarkably diverse

International team creates first chimeric human

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Flu vaccine offering decent levels of protection this winter, new data show

After affirmative action ruling, medical educators look to 'holistic review'

Biden's 'march

Supreme Court strikes down use of affirmative action

Scientists unlock the key to scar

focus

Harvard's David Sinclair gets blowback over aging

Pregnant women don't need prenatal multivitamins, study concludes

The untold story of TV’s first prescription drug ad

Why getting cancer drugs just got harder for rural patients

Microsoft's Peter Lee: Generative AI could help doctors be more human

Families look for replacement for GSK asthma drug Flovent

knowledge

knowledge

hotspot

Wikipedia